Grant C. Bogle

Insider Reports History

Entity
Individual
Location
C/O Tesaro, Inc., 1000 Winter Street, Suite 3300, Waltham, MA
Signature
/s/ Nathan McConarty, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Grant C. Bogle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Director Class A Common Stock 3.2K $308K $96.25 Dec 5, 2024 Direct
Nuvalent, Inc. Director Stock Option (Right to Buy) 4.85K Dec 5, 2024 Direct
Epizyme, Inc. President and CEO, Director Common Stock, par value $0.0001 0 $1.41 Aug 12, 2022 Direct
Epizyme, Inc. President and CEO, Director Stock Option (Right to Buy) 0 Aug 9, 2022 Direct

Insider Reports Filed by Grant C. Bogle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NUVL Nuvalent, Inc. Dec 5, 2024 2 $0 4 Dec 9, 2024 Director
NUVL Nuvalent, Inc. Dec 5, 2024 0 $0 3 Dec 9, 2024 Director
EPZM Epizyme, Inc. Aug 12, 2022 2 $0 4 Aug 16, 2022 President and CEO, Director
EPZM Epizyme, Inc. Aug 9, 2022 6 $106K 4 Aug 11, 2022 President and Chief Executive Officer, Director
EPZM Epizyme, Inc. Mar 17, 2022 1 $0 4 Mar 21, 2022 President and Chief Executive Officer, Director
EPZM Epizyme, Inc. Feb 2, 2022 2 $0 4 Feb 4, 2022 President and Chief Executive Officer, Director
EPZM Epizyme, Inc. Aug 16, 2021 2 $0 4 Aug 18, 2021 President and Chief Executive Officer, Director
EPZM Epizyme, Inc. Jun 11, 2021 2 $0 4 Jun 15, 2021 Director